Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ION+EMI: Intermittent Naltrexone + EMI for Meth Use in MSM
NCT04791969Phase 2Completed
- Start
- Dec 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in methamphetamine use disorder (MUD) comparing Naltrexone + EMI with Placebo + EMI (2 arms). Primary endpoint: Number of People With Meth-positive Urine Tests at Weekly Visits. Started Dec 2021; status: completed.
02
Drugs
naltrexone
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT04791969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04791969.